Choose the best treatment option for your patient

Objective of the mYXpression rheumatoid Test

• To help you decide on a therapy and be confident about that choice.

• To offer new prospects for healing patients with rheumatoid arthritis.

• To increase the chances of patients reaching lasting remission and optimise the medico-economic aspect by decreasing costs.

Methodology of the technology

The mYXpression rheumatoid Test is based on three major areas of expertise:

• Mastery of the latest RNA transcriptome sequencing technologies (individual multi-genomic signature).

• Massive use of new information technologies and of Big Data bringing together international clinical studies (digital data base).

• The development of massive calculations and automatic learning algorithms (machine learning) to generate powerful and robust tools to make a customised decision to help the doctor and their patient throughout their therapeutic journey.

The combination of these 3 dimensions produces a custom report that is specific to the patient. This report called RITI® indicates a level of efficacy for each biotherapy.

RITI® offers real precision medicine and is a valuable aid to optimise the therapeutic strategy to adopt for the patient.

Find out more

Evidence of clinical efficacy

To better understand our technology and reassure you of the usefulness of the mYXpression rheumatoid Test, a clinical study will begin shortly. The study will enable us, in a few months, to provide you with clinical evidence as to the reliability of the results of our Test.

I would like to be informed when the clinical study starts

Frequently asked questions

Which patients are concerned by this Test? Icon plus

Two specific cases:

• Your patient has been diagnosed with rheumatoid arthritis and it is currently in therapeutic failure.

• Your patient has been diagnosed with rheumatoid arthritis and you plan to prescribe a biotherapy

How do I get the test for a patient? Icon plus

Upload or send the prescription by e-mail via our dedicated form

How it works Icon plus

• You suggest the mYXpression rheumatoid Test to your patient

• Your patient orders the Test via our platform following your request

• Your patient receives their mYbox kit in 48 hours to they can take a drop of blood for the RNA sequencing to be carried out at our genomics platform. Find out more about the mYboX kit.

• A customised RITI® report is generated for your patient and sent to them

• Your patient sends you the personal reportRITI®

Funding of the Test Icon plus

The Test is marketed at a price of 850 euros including VAT. Currently, the patient must cover the total cost.

La structuration des dossiers est en cours afin d\’obtenir l\’ensemble des éléments nécessaires permettant aux autorités françaises (ANSM,HAS) de reconnaitre l'apport de notre technologie innovante dans le parcours de soin du patient.

We are aware that the Test is costly, and we have put in place a partnership with the Cagnotte des Proches, a participatory platform for funding, specialising in healthcare. You may tell your patient about this tool so that they can obtain the amount necessary to finance the Test.

Do you have questions? Contact us.

OUR PARTNERS

Wave separation Wave separation reversed